This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
Apple | RBC Capital Markets cuts TP to $550 from $600; Outperform |
Ashmore | SocGen ups TP to 455p from 420p; Buy |
Ashmore | Jefferies ups TP to 490p from 435p; Buy |
BAE Systems | JP Morgan Cazenoveorgan Cazenove cuts rating to Underweight from Neutral |
BHP Billiton | Sanford C Bernstein ups TP to 2500p from 2450p; Outperform |
Cairn Energy | RBC Capital Markets ups TP to 440p from 400p; upgrades to Outperform from Sector Perform |
Croda | UBS downgrades to Sell from Neutral |
Debenhams | Panmure Gordon cuts TP to 88p from 90p; Hold |
Debenhams | Cantor cuts TP to 70p from 80p; downgrades to Sell from Reduce |
GlaxoSmithKline | SocGen ups TP to 1900p from 1810p; Buy |
HSBC | Liberum cuts TP to 650p from 665p, downgrades to Hold from Buy |
HSBC | Barclays maintains Overweight |
Informa | Jefferies cuts TP to 510p from 580p; downgrades to Hold from Buy |
Johnson Matthey | UBS upgrades to Buy from Neutral |
Legal & General | JP Morgan Cazenoveorgan Cazenove downgrades to Underweight from Neutral |
Marks and Spencer | Cantor downgrades to Sell from Hold |
Pearson | Jefferies cuts TP to 1240p from 1290; Hold |
Reed Elsevier | Jefferies cuts TP to 700p from 760p; downgrades to Hold from Buy |
Rentokil Initial | Goldman Sachs downgrades to Neutral from Buy |
Resolution | JP Morgan Cazenoveorgan Cazenove upgrades to Neutral from Underweight |
SAB Miller | SocGen ups TP to 3590p from 2970p; Hold |
Sports Direct | Cantor cuts TP to 440p from 460p; downgrades to Hold from Buy |
Standard Chartered | Barclays maintains Overweight |
William Hill | Deutsche Bank downgrades to Hold from Buy |
Source: Reuters News, AlphaTerminal, Dow Jones Newswires |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research